Qingfeng Pharmaceuticals is a cross-regional, production, research, science, industry and trade in one of the new pharmaceutical enterprise group, in Ganzhou, Beijing, Hangzhou, Shenzhen and Haikou and other places wholly owned two production enterprises, two sales companies, a pharmaceutical research institute and a clinical medical research institute, the existing staff of nearly 2,000 people.
Qingfeng Pharmaceuticals has been honored as one of the "High-tech Enterprises", "Top 10 Enterprises of Pharmaceutical Industry in Jiangxi Province" and "Top 50 Enterprises in Ganzhou City", "Outstanding Contribution Award Enterprise", "Best Enterprise in Ganzhou City", "Advanced Enterprise in Science and Technology Innovation of Jiangxi Province", "Patent Investment Award Enterprise "
In 2012, the Group realized sales revenue of RMB 2.5 billion and profits and taxes of RMB 430 million, which is a significant increase in all economic indicators compared with last year.
Qingfeng Pharmaceuticals adheres to the business philosophy of taking science and technology as the forerunner, and establishes the development strategy of research and development drive and product innovation, and has successively set up the Qingfeng Pharmaceutical Research Center, Qingfeng Hangzhou Institute of Pharmaceutical Research, and Qingfeng Beijing Institute of Clinical Medicine, with the research and development team consisting of a full range of multi-level scientific and technological innovation talents, such as professors, researchers, senior engineers, PhDs, and masters as the backbone. There are more than 20 new varieties under research and development, including one Class I new drug, 13 Class III new drugs, two Class V new drugs and three Class VI new drugs. With more than 20 national invention patents, the company has undertaken three major scientific and technological special projects of the National Twelfth Five-Year Plan "Creation of Major New Drugs", three projects of the National Innovation Fund for Scientific and Technological Enterprises, and three projects of the National Development and Reform Commission and the Ministry of Industry and Information Technology of the People's Republic of China "High-tech Industrialization". industrialization" project.
Qingfeng Pharmaceuticals, in line with the quality first business philosophy, focus on building domestic first-class production hardware facilities and software system, with two production bases, forming a 200 million injections, tablets 2 billion tablets, granules 100 million bags, capsules 100 million capsules, 10 tons of raw materials **** 6 series of more than 100 specifications of production capacity, with domestic and international first-class production equipment and testing equipment, all the dosage forms have been awarded the national GMP, and all the dosage forms have been awarded the national GMP. All the dosage forms have been certified by national GMP.
Qingfeng Pharmaceuticals, adhering to the business philosophy of mutual benefit***win, has established and perfected a nationwide sales network system. High-quality featured products, high-quality sales team, specialized marketing capabilities, and perfect sales and service system have won a good reputation for the enterprise.
The foundation of the industry is evergreen, always climbing the peak. Looking to the future, Qingfeng people to revitalize the national medicine as its own responsibility, Qingfeng people will be scientific and rigorous attitude, enterprising style, pragmatic style, and strive to Qingfeng to build the industry as a "century-old store", to provide more and better services for the cause of human health, and to win the respect of customers and the community, and realize the enterprise's health, We are committed to building Qingfeng into a "century-old company" in the industry, providing more and better services for human health, and realizing the healthy, virtuous and rapid development of the enterprise while winning the respect of customers and society.